These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26468222)

  • 1. Killing two birds with one stone: a case of GIST and supervening CML.
    Mehta VR; Khan U; Hoang U; Rachshtut M
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26468222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant imatinib treatment in gastrointestinal stromal tumor: which risk stratification criteria and for how long? A case report.
    Blay JY; Levard A
    Anticancer Drugs; 2016 Jan; 27(1):71-5. PubMed ID: 26457546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.
    Kyo K; Azuma M; Okamoto K; Nishiyama M; Shimamura T; Maema A; Kanamaru H; Shirakawa M; Nakamura T; Shinmura K; Koda K; Yokoyama H
    World J Surg Oncol; 2016 Mar; 14():68. PubMed ID: 26957123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.
    Fukuda S; Fujiwara Y; Wakasa T; Kitani K; Tsujie M; Yukawa M; Ohta Y; Inoue M
    J Med Case Rep; 2017 Feb; 11(1):33. PubMed ID: 28166823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
    Namikawa T; Munekage E; Munekage M; Maeda M; Yatabe T; Kitagawa H; Sakamoto K; Obatake M; Kobayashi M; Hanazaki K
    Anticancer Res; 2016 Apr; 36(4):1855-9. PubMed ID: 27069170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
    Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
    Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG).
    Duffaud F; Meeus P; Bertucci F; Delhorme JB; Stoeckle E; Isambert N; Bompas E; Gagniere J; Bouché O; Toulmonde M; Salas S; Blay JY; Bonvalot S;
    Eur J Surg Oncol; 2017 Jun; 43(6):1110-1116. PubMed ID: 28433494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
    Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
    J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A
    Ann Hematol; 2004; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resection of a Huge Gastrointestinal Stromal Tumor of the Stomach Following Neoadjuvant Chemotherapy with Imatinib].
    Sato Y; Karasawa H; Aoki T; Imoto H; Tanaka N; Watanabe K; Abe T; Nagao M; Ohnuma S; Musha H; Takahashi M; Motoi F; Naitoh T; Ishioka C; Unno M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2216-2218. PubMed ID: 28133274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy.
    Guerin A; Sasane M; Gauthier G; Keir CH; Zhdavana M; Wu EQ
    J Med Econ; 2015 Mar; 18(3):241-8. PubMed ID: 25422992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate treatment in a dog with gastrointestinal stromal tumors with a c-kit mutation.
    Irie M; Takeuchi Y; Ohtake Y; Suzuki H; Nagata N; Miyoshi T; Kagawa Y; Yamagami T
    J Vet Med Sci; 2015 Nov; 77(11):1535-9. PubMed ID: 26074249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus foliaceus associated with imatinib therapy in a patient with gastrointestinal stromal tumor.
    Chen WS; Chen YJ; Yang CS; Juan CK
    Int J Dermatol; 2018 Oct; 57(10):e93-e95. PubMed ID: 29993121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
    Reichardt P; Reichardt A
    Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy.
    Martínez-Marín V; Maki RG
    Gastroenterol Clin North Am; 2016 Sep; 45(3):477-86. PubMed ID: 27546844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia.
    Ravegnini G; Sammarini G; Angelini S; Hrelia P
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):733-42. PubMed ID: 27149004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
    JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
    Yhim HY; Lee NR; Song EK; Yim CY; Jeon SY; Lee B; Kim JA; Kim HS; Cho EH; Kwak JY
    Acta Haematol; 2016; 135(3):133-9. PubMed ID: 26535871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety profile of imatinib in CML and GIST: long-term considerations.
    Thanopoulou E; Judson I
    Arch Toxicol; 2012 Jan; 86(1):1-12. PubMed ID: 21717109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New fronts in the adjuvant treatment of GIST.
    Reichardt P; Joensuu H; Blay JY
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.